GLP‐1R agonist semaglutide protects human forebrain organoids from cholesterol‐induced neurotoxicity
Alzheimer's & Dementia · 2026-10 · 22 (10)
DOI: 10.1002/alz.71888 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 28.09.2026. Verfasst von Feifei Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biopharmaceutical and Health Engineering (iBHE), Tsinghua Shenzhen International Graduate School (SIGS), Tsinghua University, Shenzhen, …. Hauptthemen laut MEDLINE: Glucagon-Like Peptides, Cholesterol, Organoids, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, Shenzhen Medical Academy of Research and Translation, National Natural Science Foundation of China.
Abstract (Originalsprache)
INTRODUCTION Dysregulated cholesterol metabolism represents a critical metabolic stressor in the central nervous system, contributing to neuronal injury across multiple neurological conditions, including Alzheimer's disease (AD). While glucagon‐like peptide‐1 receptor (GLP‐1R) agonists show neuroprotective potential, their capacity to directly mitigate cholesterol‐induced metabolic stress in human neural cells remains to be established. METHODS Here, we modeled metabolic stress using human induced pluripotent stem cell–derived forebrain organoids exposed to cholesterol overload. The protective effects of the GLP‐1R agonist semaglutide were characterized by integrating bulk/single‐cell transcriptomics, calcium imaging, and biochemical assays. Furthermore, clinical translatability was supported by mapping organoid expression signatures against human post mortem neurodegenerative brain datasets. RESULTS Cholesterol overload induced cellular stress and transcriptomic alterations that partially overlapped with AD‐associated signatures. Semaglutide protected neural cells from lipotoxic injury. Intracellularly, GLP‐1R activation engaged the cyclic adenosine 3',5'‐monophosphate–protein kinase A and phosphoinositide 3 kinase–protein kinase B–mechanistic target of rapamycin signaling pathways, consistent with reduced lipid droplet accumulation and oxidative stress. Intercellularly, single‐cell analysis indicated partial preservation of disrupted cellular communication, including the neurotrophic midkine signaling network. Functionally, semaglutide stabilized cellular calcium activity patterns under metabolic stress. DISCUSSION These findings highlight the role of cholesterol homeostasis in maintaining neuronal integrity and position GLP‐1R signaling as a candidate protective axis under metabolic stress, offering insights into therapeutic strategies for AD and broader neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biopharmaceutical and Health Engineering (iBHE), Tsinghua Shenzhen International Graduate School (SIGS), Tsinghua University, Shenzhen, China.
- Key Laboratory of Industrial Biocatalysis, Ministry of Education, Tsinghua University, Beijing, China.
- Key Laboratory of Active Proteins and Peptides Green Biomanufacturing of Guangdong Higher Education Institutes, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
ORCID-Profile: Shaohua Ma
Förderung
- National Key Research and Development Program of China
- Shenzhen Medical Academy of Research and Translation
- National Natural Science Foundation of China
- Key-Area Research and Development Program of Guangdong
- Shenzhen Natural Science Foundation
- Stabilization Support Program of Shenzhen Science and Technology Innovation Commission
Zitieren
APA
Yu, F., Xu, J., Hou, Y., Zheng, H., Guo, L., Khutsishvili, D., Hai, C., Xu, W., Chen, B., Wang, Z., & Ma, S. (2026). GLP‐1R agonist semaglutide protects human forebrain organoids from cholesterol‐induced neurotoxicity. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71888
Vancouver
Yu F, Xu J, Hou Y, Zheng H, Guo L, Khutsishvili D, et al. GLP‐1R agonist semaglutide protects human forebrain organoids from cholesterol‐induced neurotoxicity. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71888
BibTeX
@article{Yu2026,
author = {Yu, Feifei and Xu, Jiani and Hou, Yibo and Zheng, Honghui and Guo, Lingyi and Khutsishvili, Davit and Hai, Cheng and Xu, Wenxin and Chen, Bailing and Wang, Zitian and Ma, Shaohua},
title = {GLP‐1R agonist semaglutide protects human forebrain organoids from cholesterol‐induced neurotoxicity},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {10},
doi = {10.1002/alz.71888}
}
EUVIMED